Search Results | Anesthesiology | American Society of Anesthesiologists

1-20 of 35

Sort by

Sort Order Select

Articles

A Dose-Finding Study of Sugammadex for Reversal of Rocuronium in Cardiac Surgery Patients and Postoperative Monitoring for Recurrent Paralysis

Andrew Bowdle, MD, PhD, FASE, Kishanee J Haththotuwegama, BS, Srdjan Jelacic, MD, FASE, Sharon T Nguyen, BS, Kei Togashi, MD, MPH, Kelly E Michaelsen, MD, PhD

Anesthesiology. April 2023: 10.1097/ALN.0000000000004578

DOI: https://doi.org/10.1097/ALN.0000000000004578

Published: April 2023

View article

Articles

Encapsulation Dynamics of Neuromuscular Blocking Drugs by Sugammadex

Amir Hossein Irani, Ph.D., Logan Voss, Ph.D., Nicola Whittle, M.B.Ch.B., Jamie W. Sleigh, M.D.

Anesthesiology. February 2023: 138(2):152–163

DOI: https://doi.org/10.1097/ALN.0000000000004442

Published: February 2023

View article

Articles

Ring Around the Rocuronium: Sugammadex Encapsulation Explained BIT by BIT

Holly B. Ende, James P. Rathmell, Jonathan P. Wanderer

Anesthesiology. February 2023: 138(2):A17

DOI: https://doi.org/10.1097/ALN.0000000000004472

Published: February 2023

View article

Articles

2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade

Stephan R. Thilen, M.D., M.S. (co-chair), Wade A. Weigel, M.D. (co-chair), Michael M. Todd, M.D., Richard P. Dutton, M.D., M.B.A., Cynthia A. Lien, M.D., Stuart A. Grant, M.D., Joseph W. Szokol, M.D., J.D., M.B.A., FASA, Lars I. Eriksson, M.D., Ph.D., FRCA, Myron Yaster, M.D., Mark D. Grant, M.D., Ph.D., Madhulika Agarkar, M.P.H., Anne M. Marbella, M.S., Jaime F. Blanck, M.L.I.S., M.P.A., Karen B. Domino, M.D., M.P.H.

Anesthesiology. January 2023: 138(1):13–41

DOI: https://doi.org/10.1097/ALN.0000000000004379

Published: January 2023

View article

Articles

Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative

Wade A. Weigel, M.D., Barbara L. Williams, Ph.D., Neil A. Hanson, M.D., C. Craig Blackmore, M.D., M.P.H., Randy L. Johnson, Cer.A.T., Gary M. Nissen, M.D., Andrew B. James, M.D., Wyndam M. Strodtbeck, M.D.

Anesthesiology. June 2022: 136(6):901–915

DOI: https://doi.org/10.1097/ALN.0000000000004174

Published: June 2022

View article

Articles

Postoperative Pulmonary Complications’ Association with Sugammadex versus Neostigmine: A Retrospective Registry Analysis

Gen Li, M.Stat., M.Chem., Robert E. Freundlich, M.D., M.S., M.S.C.I., Rajnish K. Gupta, M.D., Christina J. Hayhurst, M.D., Chi H. Le, B.S., Barbara J. Martin, R.N., M.B.A., Matthew S. Shotwell, Ph.D., Jonathan P. Wanderer, M.D., M.Phil., F.A.S.A., F.A.M.I.A.

Anesthesiology. June 2021: 134(6):862–873

DOI: https://doi.org/10.1097/ALN.0000000000003735

Published: June 2021

View article

Articles

Sugammadex and Postoperative Pulmonary Complications: Is Stronger Evidence Required?

Kate Leslie, M.B.B.S., M.D., M.Epid., M.Hlth.Serv.Mt., Hon.D.Med.Sci., F.A.N.Z.C.A., F.A.H.M.S.

Anesthesiology. June 2020: 132(6):1299–1300

DOI: https://doi.org/10.1097/ALN.0000000000003282

Published: June 2020

View article

Articles

Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis

Sachin Kheterpal, M.D., M.B.A., Michelle T. Vaughn, M.P.H., Timur Z. Dubovoy, M.D., Nirav J. Shah, M.D., Lori D. Bash, Ph.D., M.P.H., Douglas A. Colquhoun, M.B.Ch.B., Amy M. Shanks, Ph.D., Michael R. Mathis, M.D., Roy G. Soto, M.D., Amit Bardia, M.D., Karsten Bartels, M.D., Ph.D., Patrick J. McCormick, M.D., M.Eng., Robert B. Schonberger, M.D., M.H.S., Leif Saager, M.D., M.M.M.

Anesthesiology. June 2020: 132(6):1371–1381

DOI: https://doi.org/10.1097/ALN.0000000000003256

Published: June 2020

View article

Articles

Effect of a Cognitive Aid on Reducing Sugammadex Use and Associated Costs: A Time Series Analysis

Dan M. Drzymalski, M.D., Roman Schumann, M.D., Frank J. Massaro, Pharm.D., Agnieszka Trzcinka, M.D., Ruben J. Azocar, M.D.

Anesthesiology. November 2019: 131(5):1036–1045

DOI: https://doi.org/10.1097/ALN.0000000000002946

Published: November 2019

View article

Articles

Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers

Suzanne J. L. Broens, M.D., Martijn Boon, M.D., Chris H. Martini, M.D., Ph.D., Marieke Niesters, M.D., Ph.D., Monique van Velzen, Ph.D., Leon P. H. J. Aarts, M.D., Ph.D., Albert Dahan, M.D., Ph.D.

Anesthesiology. September 2019: 131(3):467–476

DOI: https://doi.org/10.1097/ALN.0000000000002711

Published: September 2019

View article

Articles

The Basics of Anesthesia, 7th Edition.

Adolfo Gonzalez, M.D., Stephen Kimatian, M.D., F.A.A.P.

Anesthesiology. December 2018: 129(6):1194–1195

DOI: https://doi.org/10.1097/ALN.0000000000002432

Published: December 2018

View article

Articles

Differences of Recovery from Rocuronium-induced Deep Paralysis in Response to Small Doses of Sugammadex between Elderly and Nonelderly Patients

Takahiro Muramatsu, M.D., Shiroh Isono, M.D., Teruhiko Ishikawa, M.D., Natsuko Nozaki-Taguchi, M.D., Junko Okazaki, M.D., Yuji Kitamura, M.D., Noriko Murakami, M.D., Yasunori Sato, Ph.D.

Anesthesiology. November 2018: 129(5):901–911

DOI: https://doi.org/10.1097/ALN.0000000000002412

Published: November 2018

View article

Articles

Reversal of Vecuronium-induced Neuromuscular Blockade with Low-dose Sugammadex at Train-of-four Count of Four: A Randomized Controlled Trial

László Asztalos, M.D., Zoltán Szabó-Maák, M.D., András Gajdos, M.D., Réka Nemes, M.D., Adrienn Pongrácz, M.D., Ph.D., Szabolcs Lengyel, Ph.D., D.Sci., Béla Fülesdi, M.D., Ph.D., D.Sci., Edömér Tassonyi, M.D., Ph.D., D.Sci.

Anesthesiology. September 2017: 127(3):441–449

DOI: https://doi.org/10.1097/ALN.0000000000001744

Published: September 2017

View article

Articles

Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities

Sorin J. Brull, M.D., F.C.A.R.C.S.I. (Hon), Aaron F. Kopman, M.D.

Anesthesiology. January 2017: 126(1):173–190

DOI: https://doi.org/10.1097/ALN.0000000000001409

Published: January 2017

View article

Articles

Innovative Disruption in the World of Neuromuscular Blockade: What Is the “State of the Art?”

Mohamed Naguib, M.B., B.Ch., M.Sc., F.C.A.R.C.S.I., M.D., Ken B. Johnson, M.D.

Anesthesiology. January 2017: 126(1):12–15

DOI: https://doi.org/10.1097/ALN.0000000000001410

Published: January 2017

View article

Articles

“To Reverse or Not To Reverse?”: The Answer Is Clear!

Glenn S. Murphy, M.D., Aaron F. Kopman, M.D.

Anesthesiology. October 2016: 125(4):611–614

DOI: https://doi.org/10.1097/ALN.0000000000001280

Published: October 2016

View article

Articles

Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents

Friederike Haerter, Cand.Med., Jeroen Cedric Peter Simons, Cand.Med., Urs Foerster, M.D., Ingrid Moreno Duarte, M.D., Daniel Diaz-Gil, Cand.Med., Shweta Ganapati, B.S., Katharina Eikermann-Haerter, M.D., Cenk Ayata, M.D., Ben Zhang, Ph.D., Manfred Blobner, M.D., Lyle Isaacs, Ph.D., Matthias Eikermann, M.D., Ph.D.

Anesthesiology. December 2015: 123(6):1337–1349

DOI: https://doi.org/10.1097/ALN.0000000000000868

Published: December 2015

View article

Articles

Efficacy of Sugammadex for the Reversal of Moderate and Deep Rocuronium-induced Neuromuscular Block in Patients Pretreated with Intravenous Magnesium: A Randomized Controlled Trial

Christoph Czarnetzki, M.D., M.B.A., Edömér Tassonyi, M.D., Ph.D., D.Sci., Christopher Lysakowski, M.D., Nadia Elia, M.D., M.Sc., Martin R. Tramèr, M.D., D.Phil.

Anesthesiology. July 2014: 121(1):59–67

DOI: https://doi.org/10.1097/ALN.0000000000000204

Published: July 2014

View article

Articles

Reversal of Neuromuscular Blockade with Sugammadex at the Reappearance of Four Twitches to Train-of-four Stimulation

Adrienn Pongrácz, M.D., Szilárd Szatmári, M.D., Ph.D., Réka Nemes, M.D., Béla Fülesdi, M.D., Ph.D., D.Sci., Edömér Tassonyi, M.D., Ph.D., D.Sci.

Anesthesiology. July 2013: 119(1):36–42

DOI: https://doi.org/10.1097/ALN.0b013e318297ce95

Published: July 2013

View article

Articles

Low-dose Sugammadex Reversal: There Is No Such Thing as a Free Lunch

Aaron F. Kopman, M.D., Sorin J. Brull, M.D., F.C.A.R.C.S.I. (Hon.)

Anesthesiology. July 2013: 119(1):10–12

DOI: https://doi.org/10.1097/ALN.0b013e318297cdda

Published: July 2013

View article

NARROW

A Dose-Finding Study of Sugammadex for Reversal of Rocuronium in Cardiac Surgery Patients and Postoperative Monitoring for Recurrent Paralysis

Encapsulation Dynamics of Neuromuscular Blocking Drugs by Sugammadex

Ring Around the Rocuronium: Sugammadex Encapsulation Explained BIT by BIT

2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade

Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative

Postoperative Pulmonary Complications’ Association with Sugammadex versus Neostigmine: A Retrospective Registry Analysis

Sugammadex and Postoperative Pulmonary Complications: Is Stronger Evidence Required?

Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis

Effect of a Cognitive Aid on Reducing Sugammadex Use and Associated Costs: A Time Series Analysis

Reversal of Partial Neuromuscular Block and the Ventilatory Response to Hypoxia: A Randomized Controlled Trial in Healthy Volunteers

The Basics of Anesthesia, 7th Edition.

Differences of Recovery from Rocuronium-induced Deep Paralysis in Response to Small Doses of Sugammadex between Elderly and Nonelderly Patients

Reversal of Vecuronium-induced Neuromuscular Blockade with Low-dose Sugammadex at Train-of-four Count of Four: A Randomized Controlled Trial

Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities

Innovative Disruption in the World of Neuromuscular Blockade: What Is the “State of the Art?”

“To Reverse or Not To Reverse?”: The Answer Is Clear!

Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents

Efficacy of Sugammadex for the Reversal of Moderate and Deep Rocuronium-induced Neuromuscular Block in Patients Pretreated with Intravenous Magnesium: A Randomized Controlled Trial

Reversal of Neuromuscular Blockade with Sugammadex at the Reappearance of Four Twitches to Train-of-four Stimulation

Low-dose Sugammadex Reversal: There Is No Such Thing as a Free Lunch

Email alerts

Email alerts

This Feature Is Available To Subscribers Only